Sign in

Filings

Finds words inside filing documents. Searching InMed Pharmaceuticals Inc.'s filings · 76 documents indexed.

9 documents · 32 matches

  1. INM InMed Pharmaceuticals Inc. 10-K 2022-09-23

    Item 9A. Controls and Procedures

    material weakness and is committed to a strong Internal Control over Financial Reporting (ICFR) environment. Management has designed and implemented
    14 matches in this document
  2. INM InMed Pharmaceuticals Inc. 8-K 2025-06-13

    Item 4.01. Changes in Registrant’s Certifying Accountant

    material weakness resulted in certain material audit adjustments in the year ended June 30, 2022 related to the presentation of pre-funded
    1 match in this document
  3. INM InMed Pharmaceuticals Inc. 10-K 2026-09-09

    Item 1A. Risk Factors

    material weaknesses identified by our management in our internal control over financial reporting. A material weakness is a deficiency, or combination
    6 matches in this document
  4. INM InMed Pharmaceuticals Inc. 10-K 2025-09-23

    Item 1A. Risk Factors

    material weaknesses identified by our management in our internal control over financial reporting. A material weakness is a deficiency, or combination
    6 matches in this document
  5. INM InMed Pharmaceuticals Inc. 10-Q 2026-11-03

    Item 6. Exhibits 32

    reporting in accordance with applicable regulatory requirements, and (ii) fully remediate any material weakness identified with respect to such internal controls;
    1 match in this document
  6. INM InMed Pharmaceuticals Inc. 10-Q 2026-05-06

    Item 6. Exhibits 36

    reporting in accordance with applicable regulatory requirements, and (ii) fully remediate any material weakness identified with respect to such internal controls;
    1 match in this document
  7. INM InMed Pharmaceuticals Inc. 10-Q 2026-02-11

    Item 6. Exhibits 31

    reporting in accordance with applicable regulatory requirements, and (ii) fully remediate any material weakness identified with respect to such internal controls;
    1 match in this document
  8. INM InMed Pharmaceuticals Inc. 10-Q 2025-11-06

    Item 6. Exhibits 30

    reporting in accordance with applicable regulatory requirements, and (ii) fully remediate any material weakness identified with respect to such internal controls;
    1 match in this document
  9. INM InMed Pharmaceuticals Inc. 10-Q 2025-05-12

    Item 6. Exhibits 34

    reporting in accordance with applicable regulatory requirements, and (ii) fully remediate any material weakness identified with respect to such internal controls;
    1 match in this document

Page 1 of 1 · 9 documents